Literature DB >> 10406929

Chlorophyllin chemoprevention in trout initiated by aflatoxin B(1) bath treatment: An evaluation of reduced bioavailability vs. target organ protective mechanisms.

V Breinholt1, D Arbogast, P Loveland, C Pereira, R Dashwood, J Hendricks, G Bailey.   

Abstract

Chlorophyllin (CHL) is known to inhibit DNA adduction and hepatocarcinogenesis in trout when administered at doses up to 4000 ppm in the diet with aflatoxin B(1) (AFB(1)). The principal protective mechanism is believed to involve CHL:AFB(1) complex formation, which may reduce systemic carcinogen absorption. However, mechanisms operative within the target organ in situ have not been ruled out. The present study used alternative CHL and AFB(1) exposures as well as hepatic metabolism studies to distinguish these mechanisms. Duplicate lots of 150 rainbow trout each were initiated by brief water bath exposure to 0.1 ppm AFB(1), with or without 500 ppm CHL in the water. The addition of 500 ppm CHL to the water bath, under conditions where AFB(1) is calculated to be >99% sequestered as the CHL:AFB(1) complex, reduced hepatic AFB(1)-DNA adduction by 95% and reduced hepatocarcinogenesis from 20.5% to 2%, compared with exposure to AFB(1) alone. Inclusion of 500 ppm CHL in the water bath also significantly reduced total body burden and hepatic levels of AFB(1) as well as AFB(2), a structural analogue of AFB(1) unable to directly form the 8,9-epoxide proximate electrophile but equally capable of complexing with CHL. By contrast, internal target organ CHL loading by pretreatment of trout with 4000 ppm dietary CHL for 7 days prior to (and 2 days following) AFB(1) waterbath exposure had no effect on AFB(1)-DNA adduction or tumorigenicity. Dietary CHL up to 8000 ppm had no effect on hepatic CYP2K1, CYP1A, glutathione transferase, UDP-glucuronosyl transferase, or, with one exception, the relative ratios among hepatic AFB(1) metabolites in vivo. These results support the hypothesis that CHL:AFB(1) complex formation and reduced systemic AFB(1) bioavailability is a principal mechanism for CHL chemoprevention in this model and that in situ target organ inhibitory mechanisms are relatively insignificant. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10406929     DOI: 10.1006/taap.1999.8696

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

1.  Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer.

Authors:  P A Egner; J B Wang; Y R Zhu; B C Zhang; Y Wu; Q N Zhang; G S Qian; S Y Kuang; S J Gange; L P Jacobson; K J Helzlsouer; G S Bailey; J D Groopman; T W Kensler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

2.  Treatment of ichthyophthiriasis with photodynamically active chlorophyllin.

Authors:  D-P Häder; J Schmidl; R Hilbig; M Oberle; H Wedekind; P R Richter
Journal:  Parasitol Res       Date:  2015-12-23       Impact factor: 2.289

Review 3.  Use of Accelerator Mass Spectrometry in Human Health and Molecular Toxicology.

Authors:  Heather A Enright; Michael A Malfatti; Maike Zimmermann; Ted Ognibene; Paul Henderson; Kenneth W Turteltaub
Journal:  Chem Res Toxicol       Date:  2016-10-11       Impact factor: 3.739

4.  Identifying efficacious approaches to chemoprevention with chlorophyllin, purified chlorophylls and freeze-dried spinach in a mouse model of transplacental carcinogenesis.

Authors:  David J Castro; Christiane V Löhr; Kay A Fischer; Katrina M Waters; Bobbie-Jo M Webb-Robertson; Roderick H Dashwood; George S Bailey; David E Williams
Journal:  Carcinogenesis       Date:  2008-12-10       Impact factor: 4.944

5.  Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B(1) pharmacokinetics in human volunteers.

Authors:  Carole Jubert; John Mata; Graham Bench; Roderick Dashwood; Cliff Pereira; William Tracewell; Kenneth Turteltaub; David Williams; George Bailey
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

6.  Low-dose dietary chlorophyll inhibits multi-organ carcinogenesis in the rainbow trout.

Authors:  Michael T Simonich; Tammie McQuistan; Carole Jubert; Cliff Pereira; Jerry D Hendricks; Michael Schimerlik; Benzan Zhu; Roderick H Dashwood; David E Williams; George S Bailey
Journal:  Food Chem Toxicol       Date:  2007-11-04       Impact factor: 6.023

7.  Fighting fish parasites with photodynamically active chlorophyllin.

Authors:  D-P Häder; J Schmidl; R Hilbig; M Oberle; H Wedekind; P Richter
Journal:  Parasitol Res       Date:  2016-03-03       Impact factor: 2.289

8.  Chlorophyll-related compounds inhibit cell adhesion and inflammation in human aortic cells.

Authors:  Kuan-Hung Lin; Ching-Yun Hsu; Ya-Ping Huang; Jun-You Lai; Wen-Bin Hsieh; Meng-Yuan Huang; Chi-Ming Yang; Pi-Yu Chao
Journal:  J Med Food       Date:  2013-09-25       Impact factor: 2.786

Review 9.  The molecular epidemiology of chronic aflatoxin driven impaired child growth.

Authors:  Paul Craig Turner
Journal:  Scientifica (Cairo)       Date:  2013-12-19

Review 10.  Cancer interception by interceptor molecules: mechanistic, preclinical and human translational studies with chlorophylls.

Authors:  Roderick H Dashwood
Journal:  Genes Environ       Date:  2021-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.